These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa? Veltel S; Wittinghofer A Expert Opin Ther Targets; 2009 Oct; 13(10):1239-51. PubMed ID: 19702441 [TBL] [Abstract][Full Text] [Related]
8. Prospects for retinal gene replacement therapy. Smith AJ; Bainbridge JW; Ali RR Trends Genet; 2009 Apr; 25(4):156-65. PubMed ID: 19303164 [TBL] [Abstract][Full Text] [Related]
9. [Neuroprotective gene therapy to treat patients with retinitis pigmentosa]. Ikeda Y; Ishibashi T Fukuoka Igaku Zasshi; 2010 Sep; 101(9):183-9. PubMed ID: 21226311 [No Abstract] [Full Text] [Related]
10. [Recent progress in molecular genetics and gene therapy for retinitis pigmentosa]. Wang DY; Fan BJ; Wu XQ; Chan WM; Lam SC; Pang CP Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):188-92. PubMed ID: 15840355 [TBL] [Abstract][Full Text] [Related]
11. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883 [TBL] [Abstract][Full Text] [Related]
16. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Frasson M; Sahel JA; Fabre M; Simonutti M; Dreyfus H; Picaud S Nat Med; 1999 Oct; 5(10):1183-7. PubMed ID: 10502823 [TBL] [Abstract][Full Text] [Related]